Completed PHASE4 INTERVENTIONAL 2-arm NCT00678691

An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue

Sponsor: State University of New York - Upstate Medical University

Updated 6 times since 2017 Last updated: Dec 9, 2014 Started: Aug 31, 2007 Primary completion: Jun 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Fibromyalgia, Primary, this trial is completed. The trial is conducted by State University of New York - Upstate Medical University and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York - Upstate Medical University

Data source: State University of New York - Upstate Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Syracuse, United States